These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 22369685

  • 1. Targeted therapy of hepatocellular carcinoma: present and future.
    Chan SL, Yeo W.
    J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW, Poon RT.
    Oncology; 2007 May; 72 Suppl 1():30-44. PubMed ID: 18087180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeted therapy of hepatocellular cancer.
    Wysocki PJ.
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [Abstract] [Full Text] [Related]

  • 7. Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
    Cheng AL, Shen YC, Zhu AX.
    Oncology; 2011 Feb; 81(5-6):372-80. PubMed ID: 22269894
    [Abstract] [Full Text] [Related]

  • 8. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
    Yau T, Pang R, Chan P, Poon RT.
    Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
    [Abstract] [Full Text] [Related]

  • 9. Met as a therapeutic target in HCC: facts and hopes.
    Giordano S, Columbano A.
    J Hepatol; 2014 Feb; 60(2):442-52. PubMed ID: 24045150
    [Abstract] [Full Text] [Related]

  • 10. Molecular targeted therapies in hepatocellular carcinoma.
    Tanaka S, Arii S.
    Semin Oncol; 2012 Aug; 39(4):486-92. PubMed ID: 22846865
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The evolving landscape of therapeutic drug development for hepatocellular carcinoma.
    Chong DQ, Tan IB, Choo SP, Toh HC.
    Contemp Clin Trials; 2013 Nov; 36(2):605-15. PubMed ID: 23591326
    [Abstract] [Full Text] [Related]

  • 14. Targeted therapies for hepatocellular carcinoma.
    Skelton MR, O'Neil B.
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):209-18. PubMed ID: 18391920
    [Abstract] [Full Text] [Related]

  • 15. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P, Piguet AC, Dufour JF.
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [Abstract] [Full Text] [Related]

  • 16. Novel molecular therapies in hepatocellular carcinoma.
    Faivre S, Bouattour M, Raymond E.
    Liver Int; 2011 Jan; 31 Suppl 1():151-60. PubMed ID: 21205154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
    Zhou Q, Lui VW, Yeo W.
    Future Oncol; 2011 Oct; 7(10):1149-67. PubMed ID: 21992728
    [Abstract] [Full Text] [Related]

  • 19. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX.
    Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
    [Abstract] [Full Text] [Related]

  • 20. Emerging targeted strategies in advanced hepatocellular carcinoma.
    Finn RS.
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.